Orchid Pharma Limited — Others, 29-03-2025: Action(s) taken or orders passed

Orchid Pharma Limited has acknowledged receiving cautionary letters from the BSE and NSE regarding late disclosures for analyst meetings in June 2024. The company was noted for failing to report meeting schedules two working days in advance, as mandated by SEBI regulations. Despite this compliance issue, Orchid Pharma states that it believes the letters will not materially impact its financials or operations. Investors should watch for governance improvements and future adherence to disclosure timelines, which could influence market confidence positively.